소장 협착 소견을 보인 외투세포림프종 1예 = CASE REPORT : A Case of Mantle Cell Lymphoma Presenting as a Small Intestinal Stricture

다국어 초록 (Multilingual Abstract)

Mantle cell lymphoma (MCL) is a subtype of B-cell non-Hodgkin`s lymphoma (NHL), accounting for 3-10% of NHL. MCL involves the gastrointestinal (GI) tract in 10-30% of patients and common sites of MCL GI tract involvement are the colorectum and stomach, but any region of the GI tract may be involved. GI tract involvement by MCL usually presents in the form of multiple lymphomatous polyposis involving several segments of the GI tract. A few cases of MCL presenting with a GI tract stricture have been reported. Here, we present a rare case of a small intestinal stricture caused by MCL and review the literature of this disease. (Intest Res 2012;10:300-304)

참고문헌 (Reference)

1 Tamura S, "Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract" 39 : 995-1000, 2004

2 Cornes JS, "Multiple lymphomatous polyposis of the gastrointestinal tract" 14 : 249-257, 1961

3 Smir BN, "Molecular evidence links lymphomatous polyposis of the gastrointestinal tract with mantle cell lymphoma" 26 : 1282-1285, 1995

4 Norton AJ, "Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period" 6 : 249-256, 1995

5 Argatoff LH, "Mantle cell lymphoma: a clinicopathologic study of 80 cases" 89 : 2067-2078, 1997

6 Weisenburger DD, "Mantle cell lymphoma--an entity comes of age" 87 : 4483-4494, 1996

7 Hotta K, "Mantle cell lymphoma presenting as multiple lymphomatous polyposis spreading widely to the small intestine and diagnosed by double-balloon endoscopy" 39 (39): E347-E348, 2007

8 Pileri SA, "Mantle cell lymphoma" 94 : 1488-1492, 2009

9 Nodit L, "Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes" 34 : 1030-1034, 2003

10 Lenz G, "Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)" 23 : 1984-1992, 2005

11 Hwan-HoonChung, "Imaging Findings of Mantle Cell Lymphoma Involving Gastrointestinal Tract" 연세대학교의과대학 44 (44): 49-57, 2003

12 Romaguera JE, "High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine" 23 : 7013-7023, 2005

13 Romaguera JE, "Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma" 97 : 586-591, 2003

14 Ghielmini M, "Effect of single- agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK)" 23 : 705-711, 2005

15 Meral M, "Diffuse gastrointestinal involvement of mantle cell lymphoma" 19 : 117-120, 2008

16 Leonard JP, "Biology and management of mantle cell lymphoma" 13 : 342-347, 2001

17 Orchard J, "A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease" 101 : 4975-4981, 2003

18 Harris NL, "A revised European- American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group" 84 : 1361-1392, 1994